Atonarp announces innovative new metrology platform Aston, aimed at increasing yield, throughput, and efficiency in semiconductor manufacturing processes

TOKYO, July 15, 2021 — Atonarp, a leading manufacturer of molecular sensing and diagnostics products for the semiconductor, healthcare, and pharma industries, today announced Aston, an innovative in-situ semiconductor metrology platform with an integrated plasma ionization source. Atonarp’s Aston…

HICOOL 2021 Global Entrepreneurship Competition (Preliminary Round) is Launched in Full Swing on July 10th

BEIJING, July 11, 2021 — On July 10th, HICOOL 2021 Global Entrepreneurship Competition (Qualifying Round) is launched in full swing. A total of 1,237 startups shortlisted for the preliminary round compete off-line in Beijing and online in a global context in six major industries: New Generation Information Technology, Cultural Creativity,…

Clarivate Report Demonstrates that Nations or Institutions with Diverse Research Priorities Respond More Comprehensively to Unprecedented Scientific Challenges

Forward-looking approach offers a valuable new tool for anticipating and preparing for the unexpected LONDON, June 16, 2021 — Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new Global Research…

Medidata Becomes First Company to Offer End-to-End, Unified, Secure Platform for Decentralization of Clinical Trials (DCT)

The first company in the world to unify direct patient data capture technology with study oversight and monitoring, Medidata redefines end-to-end decentralization for sponsors and CROs The unique Medidata Trial Dial™ concept provides the industry’s highest level of customization…

Enamine implements CDD Vault to digitalize its integrated medicinal chemistry, ADME-PK and screening services

The company’s expansion in the biological assay space aided by the data platform SAN FRANCISCO and KYIV, Ukraine, June 10, 2021 — Enamine, a leading provider of R&D Services as well as Screening Compounds, Fragments, Building Blocks and specialized libraries for Drug Discovery, announced…

AI-based Analysis of Cancer Tissue Predicts Response to Immunotherapy–Findings to Be Presented at ASCO 2021

Lunit to present four abstracts including one in a ‘Poster Discussion Session’ AI-based tissue analysis platform ‘Lunit SCOPE’ to be launched within the second half of 2021: "We aim to make our AI the new standard for cancer treatment" SEOUL, Korea, June 4, 2021 — A new…

PolyU develops biomimetic nanosheet for cancer therapy and imaging

HONG KONG, May 31, 2021 — A research team from the Department of Applied Biology and Chemical Technology (ABCT) of The Hong Kong Polytechnic University (PolyU) has developed a novel type of biomimetic nanosheet with a multi-modal imaging function, which can track tumour development and treatment processes in real-time. By…

Revolutionary X-ray Technology From Australia to Transform American Airport Security

SeaTac chosen for Micro-X Inc’s USA headquartersOfficial Opening at 10 am PDT, Friday May 28855 S 192nd Street, Suite B600, Seattle, WA 98148 With: Congressman Adam Smith, chair of the House Armed Services Committee Brigadier Hugh Meggitt representing Australian Defence Staff, Embassy of Australia Stephen Patterson,…

Neteera makes annual CNBC Disruptor 50 list second year running

JERUSALEM, May 27, 2021 — Neteera, global leader in contactless vital signs sensing, has been named for the second year running to the CNBC Disruptor 50, an annual list of private venture-backed companies transforming the economy and the way we live. Over 1,500 nominees contended for the prestigious award this…

PMB and CEA Announce the Commissioning of iMiGiNE at Frederic Joliot Hospital (Orsay), Paving the Way for Next Generation Molecular Imaging Diagnostics

PEYNIER, France, May 12, 2021 — An automated radiopharmaceutical production system iMiGiNE has been installed in Frederic Joliot Hospital (CEA) in Orsay, France and commissioned in December 2020. This disruptive system will revolutionize the radiopharmaceutical production, access and distribution. iMiGiNE will allow clinical…